|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash from operating activities: | |||||
| Amortization of right to use asset | |||||
| Stock-based compensation expense | |||||
| Non-cash interest expense | |||||
| Change in fair value of derivatives | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accrued interest on convertible notes payable and convertible line of credit – related party | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Net cash from operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Net cash from investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Net proceeds from convertible line of credit – related party | |||||
| Net proceeds from issuance of common stock | |||||
| Net proceeds from exercise of common stock options and warrants | |||||
| Net cash from financing activities | |||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | |||||
| CASH AND CASH EQUIVALENTS, END OF PERIOD | |||||
| NONCASH FINANCING ACTIVITIES: | |||||
| Payment of preferred stock dividends in common stock | |||||
| Reclassification of accrued bonus to additional paid in capital | |||||
| Common stock purchase warrants issued in connection with related party line of credit | |||||
| Noncash right to use lease asset | |||||
| Conversion of Series A preferred to common stock | |||||
Loading...